safinamide Articles

Newron executes safinamide deal with Zambon; new Ph III data; management changes

15 May 2012

Newron licenses safinamide to Zambon for EU and USA

9 April 2012

Newron updates on deal Meiji Seika Pharma deal; Almirall out-licenses in Korea

14 February 2012

Newron gets new partner for safinamide

6 January 2012

Newron says it has received interest in safinamide, rejected by Merck Serono

18 November 2011

Repligen to buy Novozymes Biopharma Sweden business for $23 upfront; Biotie pulls out of Newron acquisition

28 October 2011

Merck returns safinamide rights to Newron; ImmuPharma regains Lupuzor from Cephalon

24 October 2011

Newron gets two drugs from Merck Serono under broader CNS collaboration

4 April 2011

Showing 1-8 of 8 articles

Go to beginningPrevious
  • 1
NextGo to end